Osteoarthritis of the hand: A modifiable disease

Journal of Hand Therapy

Volumn 13, Issue 2, 2000, Pages 79-89

  Burkholder, Janet F ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CAPSAICIN; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOXYCYCLINE; EDETIC ACID; HYDROXYCHLOROQUINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SALICYLIC ACID METHYL ESTER;

AGING; ARTICULAR CARTILAGE; CLINICAL EXAMINATION; DIET; DIGESTIVE SYSTEM ULCER; DRUG CHOICE; DRUG EFFICACY; ESTROGEN METABOLISM; GENETIC SUSCEPTIBILITY; GOUT; HAND; HEMOCHROMATOSIS; HUMAN; INFLAMMATION; OBESITY; OCHRONOSIS; OSTEOARTHRITIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; WEIGHT BEARING; WILSON DISEASE;

EID: 0034080348     PISSN: 08941130     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0894-1130(00)80032-0     Document Type: Article

References (44)

1. Felson D. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev. 1988;10:1-28.
2. Kraus VB. Pathogenesis and treatment of osteoarthritis. Med Clin North Am. 1997;81(1):85-112.
3. Chaisson CE, Zhang Y, McAlinden TE, et al. Radiographic hand osteoarthritis: incidence, patterns, and influence of preexisting disease in a population-based sample. J Rheumatol. 1997;24(7):1337-13.
4. Hirsch R, Lethbridge-Cejku M, et al. Familial aggregation of osteoarthritis: data from the Baltimore Longitudinal Study on Aging. Arthritis Rheum. 1998;41(7):1227-32.
5. Schumacher R (ed). Primer on the Rheumatic Diseases. 10th ed. Atlanta, Ga: Arthritis Foundation, 1993:3.
6. Lawrence JS. Rheumatism in cotton operatives. Br J Indust Med. 1961:18:270-6.
7. Hardingham TE, Venn G, Bayliss MT. Chondrocyte responses in cartilage and experimental osteoarthritis. Br J Rheumatol. 1991;30(S1):32-7.
8. Pelletier JP, Martel-Pelletier J, Howell DS. Etiopathogenesis of osteoarthritis. In: Koopman WJ (ed). Arthritis and Allied Conditions: A Textbook of Rheumatology. 13th ed. Baltimore, Md: Williams & Wilkins, 1997:1969-84.
9. Dieppe P, Cushnaghan J, Young P, Kirwin J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis. 1993; 52:557-63.
10. Myers S, Brandt K, Eilam O. Even low-grade synovitis significantly accelerates the clearance of protein from the canine knee. Arthritis Rheum. 1995;38:1085-91.
11. Kelley W (ed). The Textbook of Rheumatology. Philadelphia, Pa: Saunders, 1993:1704.
12. Chaisson CE, Zhang Y, Sharma L, Kennel W, Felson DT. Grip strength and the risk of developing radiographic hand osteoarthritis: results of the Framingham study. Arthritis Rheum. 1999;42(1):33-8.
13. Vikkula M, Palotie A, Ritvaniemi P, et al. Early onset osteoarthritis linked to the type II collagen gene: detailed clinical phenotype and further analysis of the gene. Arthritis Rheum. 1993;36:401-9.
14. Stickler GB, Belau PG, Farrell FJ, Hayes AC. Hereditary progressive arthroopthalmopathy. Mayo Clin Proc. 1965;40:433-5.
15. Johnson H, Valtysdottir ST, Kjartannsson O, Brekkan A. Hypermobility associated with osteoarthritis of the thumb base: a clinical and radiological subset of hand osteoarthritis. Ann Rheumatol Dis. 1996:55(8)540-3.
16. Carman WJ, Soweres MF, Hawthorne VM, Weissfeld LA. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol. 1994;139:119-29.
17. Cicuttini FM, Baker JR, Spector TD. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol. 1996;23(7):1221-6.
18. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1988;41(8):1343-55.
19. Radin EL. Mechanical aspects of osteoarthritis. Bull Rheumatol Dis. 1996;358:13-20.
20. Sowers M, Zobel D, Weissfeld L, Hawthorne VM, Carman W. Progression of osteoarthritis of the hand and metacarpal bone loss: a twenty-year follow-up of incident cases. Arthritis Rheum. 1991;34:36-42.
21. Nevitt MC, Cummings SR, Lane NE, et al. Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum. 1995;38:907-16.
22. Nevitt MC, Cummings SR, Lane NE, et al. The association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Arch Intern Med. 1996; 156:2073-80.
23. Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB. Estrogen use and radiographic osteoarthritis of the knee in women: the Framingham Osteoarthritis study. Arthritis Rheum. 1990;33:525-32.
24. Schumacher HR, Holdsmith DE. Ochronotic arthropathy, part 1: clinicopathologic studies. Semin Arthritis Rheum. 1977;6: 207-46.
25. Lacks S, Jacobs RP. Acromegalic arthropathy: a reversible rheumatic disease. J Rheumatol. 1986;13:634-6.
26. Krane S. Paget's disease of bone. In: Klippel J (ed). Primer on the Rheumatic Diseases, 11th ed. Atlanta, Ga: Arthritis Foundation, 1998.
27. Rathakrishnan C, Tiku K, Raghavan A, Tiku ML. Release of oxygen radicals by articular chondrocytes: a study of luminol-dependent chemoluminescence and hydrogen peroxide secretion. J Bone Miner Res. 1992;7:1139-48.
28. McAlinden T, Felson D. Nutrition: risk factors for osteoarthritis. Ann Rheumatol Dis. 1997;56(7):397-400.
29. McAlindon T, Felson D, Zhang Y, et al. Relationship of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med. 1996;125(5):353-9.
30. Ishizue KK, Ehrlich MG, Mankin HJ. Drug-induced inhibition of proteoglycanase activity in the Hulth-Telhag model. J Orthop Res. 1989;7:806.
31. Greenwald R, Golub L, Lavietes B, Ramamurthy NS, Gruber B, McNamara TF. Tetracyclines inhibit synovial collagenase in vivo and in vitro. J Rheumatol. 1987;14:28.
32. Breedveld FC, Dijkmans BA, Mattie H. Monocycline therapy for rheumatoid arthritis: an open dose finding study. J Rheumatol; 1990;17:43.
33. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an anti-inflammatory dose of ibuprofen and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991;325:87-91.
34. Lane NE, Thompson JM. Management of osteoarthritis in the primary care setting: an evidence-based approach to treatment. Am J Med. 1997;103(6A):25S-30S.
35. Bryant LR, Des Rosier KF, Carpenter MT. Hydroxy-chloroquine in the treatment of erosive osteoarthritis. J Rheumatol. 1995;22:1527-31.
36. Pelletier JP, Martel-Pelletier J. The therapeutic effects of NSAID and corticosteroids in osteoarthritis: to be or not to be. J Rheumatol. 1989;16(3):266-9.
37. Pelletier JP, Martel-Pelletier J. Evidence for the involvement of interleukin-1 in human osteoarthritis cartilage degradation: protective effect of NSAIDs. J Rheumatol. 1989;18(S):19-27.
38. Mochan E, Uhl J, Newton R. Evidence that interleukin-1 induction of synovial cell plasminogen activator is mediated via prostaglandin E2 and cAMP. Arthritis Rheum. 1986;29: 1078-84.
39. Walker JS, Sheather-Reid RB, Carmody JJ, Vial JH, Day R. Nonsteroidal anti-inflammatory drugs in rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 1997;40(11):1944-54.
40. Singh G, Ramey DR, Terry R, Kraishi M, Triadafilopoulis G. NSAID effects on the GI tract: an ever-widening spectrum. Arthritis Rheum. 1997;40:S93.
41. Singh G, Triadafilopoulis G. Epidemiology of NSAID-induced GI complications. J Rheumatol. 1999;26(suppl):18-24.
42. Hallas J, Lauritsen J, Villadsen HD, Gram LF. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high risk groups by excess risk estimates. Scand J Gastroenterol. 1995;30:438-44.
43. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol. 1997;24(S49):15-9.
44. Geis GS, Hubbard R, Callison D, Yu S, Zhao W. Safety and efficacy of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis. Arthritis Rheum. 1998;41(S9):S364.